Cha University
Clinical trials sponsored by Cha University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Scientists hunt for genetic signs to personalize bile duct cancer therapy Results expected Sep 2026 (estimated)
- Blood test may replace biopsies for bile duct cancer patients Results expected Dec 2026 (estimated)
- Suicide gene stem cells take aim at glioblastoma Results expected Dec 2026 (estimated)
- Blood test could replace needle biopsies for bile duct cancer patients Results expected Aug 2027 (estimated)
- Can an Anti-Inflammatory drug make liver cancer immunotherapy safer? Results expected Sep 2027 (estimated)
-
Robotic hip brace may help tame blood sugar spikes after eating
Disease control CompletedThis study tests whether walking with a wearable hip exoskeleton can improve blood sugar control after meals in people with type 2 diabetes. Participants walk for 30 minutes after a meal, either without assistance or wearing the exoskeleton in two different support modes. The goa…
Sponsor: CHA University • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Could a common steroid save lives in sepsis? new trial investigates
Disease control CompletedThis study tested whether giving the steroid dexamethasone early to people with severe sepsis is safe and helps them survive. It included 102 high-risk patients and measured deaths within 28 and 90 days. The goal was to see if this simple treatment could improve outcomes in a lif…
Phase 1/2 • Sponsor: CHA University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Robotic hip brace may help control blood sugar after eating
Knowledge-focused CompletedThis study explores whether walking with a wearable hip exoskeleton changes how the body handles blood sugar after a meal. Healthy adults aged 20 to 65 walked with and without the device, and their glucose and heart rate were measured. The goal is to see if the exoskeleton offers…
Sponsor: CHA University • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC
-
Liver cancer drug combo shows different results in different organs
Knowledge-focused CompletedThis study looked at how a combination of two drugs (atezolizumab and bevacizumab) works on liver cancer tumors in different parts of the body. Researchers wanted to see if the drugs work better on tumors in some organs than others. The study included 131 people with advanced liv…
Sponsor: CHA University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Scientists hunt for clues to predict liver cancer drug response
Knowledge-focused CompletedThis completed study analyzed tumor and blood samples from 166 people with advanced liver cancer who received a combination of atezolizumab and bevacizumab. The goal was to find biomarkers—biological clues—that could predict how well a patient responds to treatment and how long t…
Sponsor: CHA University • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:13 UTC